Here's a research subject request, that pays you for simply talking with them. Just as an FYI. Malecare is not receiving any compensation or grant money from the researchers or from the pharmaceutical company....we just think it's a reasonable request for information about men with advanced prostate cancer. Feel encouraged to email any questions or [...]
I have not had even two seconds to write about anything I saw at the AACR meeting. It will take me a few days to decompress and process my experience. In the mean time I thought I would share the following with you about inflammation and its role in survival and cancer: Researchers from the [...]
My wife has this theory that Dev is spoiled because for the last week he has been noting that he is bored and only kids who have lots of fun all of the time would notice the few moments when they are bored. I must admit that he has said spoiled kid nonsense like [...]
I am in Washington at the AACR conference so my blog posts might be irregular until next Thursday or Friday. I will try and share any interesting or important things I see or learn while at the conference. Joel T Nowak, MA, MSW
It was announced today that the phase I/II trial of MDV3100 demonstrated positive results. MDV3100 is a novel triple-acting oral androgen receptor antagonist, the common antagonist most of us are familiar with today is Casodex. These results were published in the online April 15 version of The Lancet. […]